New preclinical model advances TCR research in immune-competent systems
Jan. 16, 2025
Most clinically relevant T-cell receptor (TCR)-engineered T cells are typically tested in immunocompromised mice, allowing human T-cell engraftment but failing to replicate the complex interactions of a functioning immune system in patients. While humanized mouse models exist, they face challenges with incomplete immune reconstitution and technical complexity.